[1] AUDI L, AHMED S F, KRONE N, et al. Genetics in endocrinology: approaches to molecular genetic diagnosis in the management of differences/disorders of sex development (DSD): position paper of EU COST Action BM 1303 ‘DSDnet’[J]. Eur J Endocrinol, 2018, 179(4):R197-R206.
[2] ANWAR A, AKHTAR M, BUSBY G. Swyer syndrome: a case of dysgerminoma solely within the fallopian tube[J]. Pediatr Adolesc Gynecol, 2021,34(6):869-871.
[3] 许晓琴,袁金娜,董关萍,等. 以乳房发育为首发表现的46,XY完全性性腺发育不良1例[J]. 中华实用儿科临床杂志,2021,36(8):620-622.
[4] BERRY D P, HERMAN E K, CARTHY T R, et al. Characterisation of eight cattle with swyer syndrome by whole-genome sequencing[J]. Anim Genet,2023 ,54(2):93-103.
[5] MORAWIECKA-PIETRZAK M, D■BROWSKA E, GLIWI■SKA A, et al. A rare case of primary amenorrhoea and breast development in a 46,XY 15-year-old girl[J]. Pediatr Endocrinol Diabetes Metab,2021,27(1):62-67.
[6] BANNOUR I, BANNOUR B, FERJANI S, et al. Swyer syndrome: a diagnostic challenge[J]. JBRA Assist Reprod, 2025,29(1):195-198.
[7] KARIMIAN N, GHADAKZADEH S, ESHRAGHI M. Swyer syndrome in a woman with pure 46,XY gonadal dysgenesis and a hypoplastic uterus: a rare presentation[J]. Fertil Steril,2010,93(1):267.e13-4.
[8] DICKEN B J, BILLMIRE D F, KRAILO M, et al. Gonadal dysgenesis is associated with worse outcomes in patients with ovarian nondysgerminomatous tumors: a report of the Children′s Oncology Group AGCT 0132 study[J]. Pediatr Blood Cancer,2018,65(4):10.1002/pbc.26913.
[9] 王文婷,吴滢,陈莲,等. 儿童性腺母细胞瘤8例临床病理学分析[J]. 中华病理学杂志,2022,51(3):224-226.
[10] 梁欢,黎思健,杨佳欣,等. Swyer综合征合并性腺非无性细胞瘤的恶性生殖细胞肿瘤15例临床分析[J]. 中华妇产科杂志,2024, 59(1):64-69.
[11] NORDENSTR?魻M A, AHMED S F, VAN DEN AKKER E, et al. Pubertal induction and transition to adult sex hormone replacement in patients with congenital pituitary or gonadal reproductive hormone deficiency: an Endo-ERN clinical practice guideline[J]. Eur J Endocrinol,2022,186(6):G9-G49.
[12] DEEB A, ALSAFFAR H, HAMZA R T, et al. Availability and access to medications for puberty induction and maintenance in adolescents with hypogonadism in the arab region[J]. Int J Clin Pract, 2022,2022:9142433.
[13] GAWLIK-STARZYK A M, WI?CEK M, MATTHEWS D, et al. Availability, usage, and preferences of estradiol and progestogen preparations for puberty induction from a multicentral perspective[J]. Horm Res Paediatr,2024,98(3):327-335.